glp-1 side effects eyes Exclusive Blurry Vision from GLP-1 Medications:

But retatrutide may be even more effective , for several reasons: Glucagon receptor activation promotes hepatic fat oxidation Reduces liver fat accumulation more robustly Improves liver enzyme levels (ALT, AST) In a subgroup analysis of the retatrutide Phase 2 trial: Patients with suspected NAFLD showed a 70%+ reduction in liver fat content , measured by MRI-PDFF These effects surpassed the reductions seen with tirzepatide and semaglutide in comparable studies Another study showed that 93% of patients on the highest dose of retatrutide had 100% resolution of fatty liver

A healthy level of glutathione supports overall liver function and helps protect the liver from oxidative damage caused by toxins and stress

doi: 10.1186/s12906-018-2180-2

Yet 6 to 7 weeks of daily treatment with semaglutide (escalated from 41 g/kg to 103 g/kg) or tirzepatide (escalated from 12 g/kg to 48 g/kg) did not produce any noticeable effect on these readouts, including Iba-1 activation, in 12-month-old 5XFAD and APP/PS1 mice (51)

Most of these medications are not FDA approved for the use of treating dysautonomias but are used off-label. Each of these has been successfully used in treating some patients